Resveratrol enhances the therapeutic effect of temozolomide against malignant glioma in vitro and in vivo by inhibiting autophagy

Chien Ju Lin, Chin Cheng Lee, Yung Luen Shih, Tsung Yao Lin, Sheng Hao Wang, Yuh Feng Lin, Chwen Ming Shih

Research output: Contribution to journalArticle

106 Citations (Scopus)

Abstract

The alkylating agent temozolomide (TMZ) is the major chemotherapeutic drug used clinically in the treatment of malignant gliomas. This study investigated the mechanism behind TMZ-induced cell death and the possibility that resveratrol might increase TMZ efficacy. TMZ induced both apoptotic cell death and cytoprotective autophagy through a reactive oxygen species (ROS) burst and extracellular signal-regulated kinase (ERK) activation, which was suppressed by resveratrol, resulting in a decrease in autophagy and an increase in apoptosis, suggesting that the ROS/ERK pathway plays a crucial role in the fate of cells after TMZ treatment. Isobolographic analysis indicated that the combination of TMZ and resveratrol has a synergistic effect. Moreover, an in vivo mouse xenograft study also showed that coadministration of resveratrol and TMZ reduced tumor volumes by suppressing ROS/ERK-mediated autophagy and subsequently inducing apoptosis. Taken together, our data indicate that TMZ-induced ROS/ERK-mediated autophagy protected glioma cells from apoptosis, and the combination of resveratrol with TMZ could improve the efficacy of chemotherapy for brain tumors.

Original languageEnglish
Pages (from-to)377-391
Number of pages15
JournalFree Radical Biology and Medicine
Volume52
Issue number2
DOIs
Publication statusPublished - Jan 15 2012

Fingerprint

temozolomide
Autophagy
Therapeutic Uses
Glioma
Extracellular Signal-Regulated MAP Kinases
Reactive Oxygen Species
Cell death
Apoptosis
Tumors
Cell Death
resveratrol
In Vitro Techniques
Chemotherapy
Alkylating Agents
Tumor Burden

Keywords

  • Apoptosis
  • Autophagy
  • ERK
  • Free radicals
  • Glioma
  • Resveratrol
  • ROS
  • Temozolomide

ASJC Scopus subject areas

  • Biochemistry
  • Physiology (medical)

Cite this

Resveratrol enhances the therapeutic effect of temozolomide against malignant glioma in vitro and in vivo by inhibiting autophagy. / Lin, Chien Ju; Lee, Chin Cheng; Shih, Yung Luen; Lin, Tsung Yao; Wang, Sheng Hao; Lin, Yuh Feng; Shih, Chwen Ming.

In: Free Radical Biology and Medicine, Vol. 52, No. 2, 15.01.2012, p. 377-391.

Research output: Contribution to journalArticle

@article{8d8d004a92fb4818803e0eed2743a2e5,
title = "Resveratrol enhances the therapeutic effect of temozolomide against malignant glioma in vitro and in vivo by inhibiting autophagy",
abstract = "The alkylating agent temozolomide (TMZ) is the major chemotherapeutic drug used clinically in the treatment of malignant gliomas. This study investigated the mechanism behind TMZ-induced cell death and the possibility that resveratrol might increase TMZ efficacy. TMZ induced both apoptotic cell death and cytoprotective autophagy through a reactive oxygen species (ROS) burst and extracellular signal-regulated kinase (ERK) activation, which was suppressed by resveratrol, resulting in a decrease in autophagy and an increase in apoptosis, suggesting that the ROS/ERK pathway plays a crucial role in the fate of cells after TMZ treatment. Isobolographic analysis indicated that the combination of TMZ and resveratrol has a synergistic effect. Moreover, an in vivo mouse xenograft study also showed that coadministration of resveratrol and TMZ reduced tumor volumes by suppressing ROS/ERK-mediated autophagy and subsequently inducing apoptosis. Taken together, our data indicate that TMZ-induced ROS/ERK-mediated autophagy protected glioma cells from apoptosis, and the combination of resveratrol with TMZ could improve the efficacy of chemotherapy for brain tumors.",
keywords = "Apoptosis, Autophagy, ERK, Free radicals, Glioma, Resveratrol, ROS, Temozolomide",
author = "Lin, {Chien Ju} and Lee, {Chin Cheng} and Shih, {Yung Luen} and Lin, {Tsung Yao} and Wang, {Sheng Hao} and Lin, {Yuh Feng} and Shih, {Chwen Ming}",
year = "2012",
month = "1",
day = "15",
doi = "10.1016/j.freeradbiomed.2011.10.487",
language = "English",
volume = "52",
pages = "377--391",
journal = "Free Radical Biology and Medicine",
issn = "0891-5849",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Resveratrol enhances the therapeutic effect of temozolomide against malignant glioma in vitro and in vivo by inhibiting autophagy

AU - Lin, Chien Ju

AU - Lee, Chin Cheng

AU - Shih, Yung Luen

AU - Lin, Tsung Yao

AU - Wang, Sheng Hao

AU - Lin, Yuh Feng

AU - Shih, Chwen Ming

PY - 2012/1/15

Y1 - 2012/1/15

N2 - The alkylating agent temozolomide (TMZ) is the major chemotherapeutic drug used clinically in the treatment of malignant gliomas. This study investigated the mechanism behind TMZ-induced cell death and the possibility that resveratrol might increase TMZ efficacy. TMZ induced both apoptotic cell death and cytoprotective autophagy through a reactive oxygen species (ROS) burst and extracellular signal-regulated kinase (ERK) activation, which was suppressed by resveratrol, resulting in a decrease in autophagy and an increase in apoptosis, suggesting that the ROS/ERK pathway plays a crucial role in the fate of cells after TMZ treatment. Isobolographic analysis indicated that the combination of TMZ and resveratrol has a synergistic effect. Moreover, an in vivo mouse xenograft study also showed that coadministration of resveratrol and TMZ reduced tumor volumes by suppressing ROS/ERK-mediated autophagy and subsequently inducing apoptosis. Taken together, our data indicate that TMZ-induced ROS/ERK-mediated autophagy protected glioma cells from apoptosis, and the combination of resveratrol with TMZ could improve the efficacy of chemotherapy for brain tumors.

AB - The alkylating agent temozolomide (TMZ) is the major chemotherapeutic drug used clinically in the treatment of malignant gliomas. This study investigated the mechanism behind TMZ-induced cell death and the possibility that resveratrol might increase TMZ efficacy. TMZ induced both apoptotic cell death and cytoprotective autophagy through a reactive oxygen species (ROS) burst and extracellular signal-regulated kinase (ERK) activation, which was suppressed by resveratrol, resulting in a decrease in autophagy and an increase in apoptosis, suggesting that the ROS/ERK pathway plays a crucial role in the fate of cells after TMZ treatment. Isobolographic analysis indicated that the combination of TMZ and resveratrol has a synergistic effect. Moreover, an in vivo mouse xenograft study also showed that coadministration of resveratrol and TMZ reduced tumor volumes by suppressing ROS/ERK-mediated autophagy and subsequently inducing apoptosis. Taken together, our data indicate that TMZ-induced ROS/ERK-mediated autophagy protected glioma cells from apoptosis, and the combination of resveratrol with TMZ could improve the efficacy of chemotherapy for brain tumors.

KW - Apoptosis

KW - Autophagy

KW - ERK

KW - Free radicals

KW - Glioma

KW - Resveratrol

KW - ROS

KW - Temozolomide

UR - http://www.scopus.com/inward/record.url?scp=84855450663&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855450663&partnerID=8YFLogxK

U2 - 10.1016/j.freeradbiomed.2011.10.487

DO - 10.1016/j.freeradbiomed.2011.10.487

M3 - Article

C2 - 22094224

AN - SCOPUS:84855450663

VL - 52

SP - 377

EP - 391

JO - Free Radical Biology and Medicine

JF - Free Radical Biology and Medicine

SN - 0891-5849

IS - 2

ER -